Choksi Laboratories (526546.BO) Stock Price

Choksi Laboratories Price

CLOSED
202.35
​
Market closed

Over the last 12 years Choksi Laboratories grew revenue by 7.2% annually, reaching 460.06 M INR. Earnings per share have grown at 4.4% per year over the last 12 years. For Choksi Laboratories, the net margin of 4.3% is up versus 0.7% a few years ago.

Choksi Laboratories stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Choksi Laboratories business model & stock analysis

Choksi Laboratories Ltd, listed on the Bombay Stock Exchange under ticker 526546.BO with ISIN INE493D01013, is a company based in Indore, India. Founded on June 13, 1994, the company operates within the Industrials sector, specifically in the Professional Services industry. Its primary business involves research, development, and analytical testing for various sectors. Choksi Laboratories provides contract laboratory services, including pharmaceutical analysis, food and beverage analysis, water analysis, and construction material analysis. The company also offers instrument calibration and validation services, covering laboratory and on-site calibration for test equipment, process equipment, and end-user equipment, as well as plant shutdown calibration. Additionally, it delivers environment management services, clinical research, consultancy, and assaying and hallmarking. The firm serves clients across pharmaceuticals, food and agricultural products, construction materials, chemicals, and environmental monitoring. Choksi Laboratories operates under the regulatory requirements of its clients and provides a range of analytical and testing solutions. The company's website is http://www.choksilab.com/.

Frequently asked questions about Choksi Laboratories

Converted at the current exchange rate, the Choksi Laboratories share trades at 1.90 EUR (202.35 INR).

The revenue of Choksi Laboratories is 460.06 M INR. This figure is based on current financial data and reflects the company's business performance.

The profit of Choksi Laboratories is 19.64 M INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Choksi Laboratories is currently 71.75. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Choksi Laboratories stock.

The price-to-sales ratio (P/S) of Choksi Laboratories is currently 3.06. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Choksi Laboratories stock.

The Eulerpool Quality Score for Choksi Laboratories is 4/10.

The ISIN of Choksi Laboratories is INE493D01013. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Choksi Laboratories is 526546.BO. The ticker symbol is used to trade Choksi Laboratories shares on the stock exchange.

Fair ValueTerminal
212.47 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Professional Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Jun 13, 1994
ISIN
INE493D01013
Cusip
Y4258C107
Market capitalization
1.41 B INRSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
29.22
P/B Ratio
5.51
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
4.53 %
Last updated Oct 18, 2026, 7:49 AM

Choksi Laboratories Peer Group

Choksi Laboratories FIGI

CAS:IN · BBG000DK8K25CAS:IB · BBG000DK8KL4